WRF Capital key facts
- WRF Capital is a other based in Seattle, Washington with 21 tracked portfolio companies.
- Notable positions include Xaira Therapeutics, Group14 Technologies, Umoja Biopharma.
About WRF Capital
WRF Capital is a direct investment firm based in Seattle, Washington. Established in 1981, it is the investment vehicle for the Washington Research Foundation that works with entrepreneurs, research institutions, other investors, and industry partners to transform great ideas into successful Washington-based businesses. The assets of the firm are managed by the executive management team.
WRF Capital portfolio at a glance
21 portfolio companies are on record for WRF Capital, including Xaira Therapeutics, Group14 Technologies and Umoja Biopharma.
19 of the 21 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 21 recorded positions
- ·Watchlist + alerts for WRF Capital's activity
Portfolio
21 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Xaira Therapeutics | Biotech | ▮ | ▮ | ▮ |
| Group14 Technologies | Other Materials | ▮ | ▮ | ▮ |
| Umoja Biopharma | — | ▮ | ▮ | ▮ |
+ 18 more companies · all 21, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about WRF Capital
- What companies does WRF Capital invest in?
- WRF Capital has 21 recorded portfolio companies, including Xaira Therapeutics, Group14 Technologies, Umoja Biopharma.